Semper Paratus Acquisition Corporation is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
Company profile
Ticker
TVGN
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
IRS number
981597194
TVGN stock data
Latest filings (excl ownership)
8-K
Tevogen Bio CEO Highlights Expected Reporting of a $94.9 Million Liability Elimination, AI Initiative, and Leadership Appointments
26 Apr 24
8-K/A
Entry into a Material Definitive Agreement
10 Apr 24
NT 10-K
Notice of late annual filing
2 Apr 24
8-K
Entry into a Material Definitive Agreement
2 Apr 24
8-K
Amendments to Articles of Incorporation or Bylaws
21 Mar 24
8-K
Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
21 Feb 24
8-K/A
Entry into a Material Definitive Agreement
20 Feb 24
CERT
Certification of approval for exchange listing
14 Feb 24
8-A12B
Registration of securities on exchange
14 Feb 24
8-K
Entry into a Material Definitive Agreement
14 Feb 24
Latest ownership filings
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 347.55 k | 347.55 k | 347.55 k | 347.55 k | 347.55 k | 347.55 k |
Cash burn (monthly) | 69.49 k | (no burn) | 201.99 k | 153.27 k | 109.08 k | 296.91 k |
Cash used (since last report) | 480.33 k | n/a | 1.40 mm | 1.06 mm | 753.96 k | 2.05 mm |
Cash remaining | -132.78 k | n/a | -1.05 mm | -711.92 k | -406.42 k | -1.70 mm |
Runway (months of cash) | -1.9 | n/a | -5.2 | -4.6 | -3.7 | -5.7 |
Institutional ownership, Q2 2022
13F holders | Current |
---|---|
Total holders | 51 |
Opened positions | 49 |
Closed positions | 2 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 40.94 mm |
Total shares | 25.76 mm |
Total puts | 0.00 |
Total calls | 347.15 k |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
TVGN Tevogen Bio | 13.28 mm | $0.00 |
Parallax Volatility Advisers | 2.29 mm | $366.00 k |
FourWorld Capital Management | 1.45 mm | $232.00 k |
Corbin Capital Partners | 1.16 mm | $186.00 k |
EHP Funds | 766.63 k | $123.00 k |
Polar Asset Management Partners | 700.00 k | $112.00 k |
MMCAP International Inc. SPC | 650.00 k | $104.00 k |
Linden Advisors | 650.00 k | $101.00 k |
Taconic Capital Advisors | 500.89 k | $80.00 k |
Periscope Capital | 372.70 k | $60.00 k |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
14 Feb 24 | Kirti Desai | Common Stock | Grant | Acquire A | No | No | 0 | 9,696,186 | 0.00 | 9,696,186 |
14 Feb 24 | Keow Lin Goh | Common Stock | Grant | Acquire A | No | No | 0 | 193,923 | 0.00 | 193,923 |
14 Feb 24 | Curtis L. Patton | Common Stock | Grant | Acquire A | No | No | 0 | 969,618 | 0.00 | 969,618 |
14 Feb 24 | Ryan H. Saadi | Common Stock | Grant | Acquire A | Yes | No | 0 | 193,923 | 0.00 | 193,923 |
14 Feb 24 | Ryan H. Saadi | Common Stock | Grant | Acquire A | No | No | 0 | 19,348,954 | 0.00 | 118,250,052 |
14 Feb 24 | Ryan H. Saadi | Common Stock | Grant | Acquire A | No | No | 0 | 98,901,098 | 0.00 | 98,901,098 |
14 Feb 24 | Susan M Podlogar | Common Stock | Grant | Acquire A | No | No | 0 | 193,923 | 0.00 | 193,923 |
News
12 Health Care Stocks Moving In Friday's After-Market Session
26 Apr 24
Why Alphabet Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
26 Apr 24
12 Health Care Stocks Moving In Friday's Pre-Market Session
26 Apr 24
12 Health Care Stocks Moving In Thursday's After-Market Session
25 Apr 24
Equifax Reports Weak Sales, Joins Synovus Financial And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
18 Apr 24
Press releases
Tevogen Bio CEO Highlights Expected Reporting of a $94.9 Million Liability Elimination, AI Initiative, and Leadership Appointments
26 Apr 24
Tevogen Bio's Chief Scientific Officer Speaks on the Harnessing of Cytotoxic T Lymphocytes (CTLs) to Target Cancers
11 Apr 24
Tevogen Bio Appoints Tapan V Shah as Head of Investor Relations and Corporate Development
3 Apr 24
Tevogen Bio Holdings Congratulates its Board Member and Esteemed Global Safety Management Expert, Victor Sordillo, on His appointment as Managing Director of Risk Advisory Services at Verita
5 Mar 24
Mittul Mehta, Head of Tevogen's Artificial Intelligence Initiative Tevogen.ai, Emphasizes Importance of Proactive Talent Development for Biopharmaceutical Sector to Allow Rapid Adoption of AI
27 Feb 24